Get 50% OFF This Summer!

Advertisement
logo

Onyx Biotec

ONYX
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement

Onyx Biotec Share price and Fundamental Analysis

View All Details
View All Details
Onyx Biotec Limited was incorporated as Onyx Biotec Private Limited', pursuant to a Certificate of Incorporation dated May 13, 2005 issued by the Registrar of Companies, Punjab, H.P. & Chandigarh. Further, Company converted into a Public Limited and the name was changed to Onyx Biotec Limited' and a fresh Certificate of Incorporation dated July 23, 2024 was issued by the Registrar of Companies, Central Processing Centre.
Company Incorporation2005
ChairmanNA
Head QuartersChandigarh
Previous NameNA

Key Metrics

Market Cap (Cr)
93.56
PE Ratio
30.9
Industry P/E
35.07
PEG Ratio
0
ROE
17.76%
ROCE
15.45%
ROA
6.45%
Total Debt (Cr)
30.17
Debt to Equity
1.07
Dividend Yield
0%
EPS
1.67
Book Value & P/B
29.9 x 1.73
Face Value
10
Outstanding Shares(Cr)
1.81
Current Ratio
2.12
EV to Sales
2.05

Stock Returns

1 Week+3.2%
1 Month+3.2%
6 Months-9.07%
1 Year-9.07%
3 Years-9.07%
5 Years-9.07%

CAGR

1 Year CAGR

Revenue Growth

-80.41%

Net Profit Growth

-56.86%

Operating Profit Growth

-67.28%

Dividend Growth

N/A

Stock Returns CAGR

-9.07%
no_data

No Stocks

Smart Score

1.6
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 65.10%

FIIs : 5.36%

DIIs : 0.00%

Public : 29.54%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
FII Shareholding Decreased by 3.36% to 5.36% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Onyx Biotec Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Onyx Biotec Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Onyx Biotec Limited was incorporated as Onyx Biotec Private Limited', pursuant to a Certificate of Incorporation dated May 13, 2005 issued by the Registrar of Companies, Punjab, H.P. & Chandigarh. Further, Company converted into a Public Limited and the name was changed to Onyx Biotec Limited' and a fresh Certificate of Incorporation dated July 23, 2024 was issued by the Registrar of Companies, Central Processing Centre.

Onyx started its operation in pharmaceutical industry with sterile water for injections with capacity of 2 lacs units per day in year 2010. Since then, Onyx is engaged in Manufacturing of Pharmaceutical Products such as sterile water ampoule, dry injection, dry syrup etc. to major corporations, which includes the top pharma companies.

Presently, the Company manufactures Sterile Water for Injections, and acts as a pharmaceutical contract manufacturer offering a comprehensive range of Dry Powder Injections and Dry Syrup for India and overseas. The core business is on providing end-to-end product development and manufacturing solutions to clients. The service include preparation and filing of regulatory dossiers in the Indian and global markets.

The Company has Unit I and Unit II manufacturing plants in Solan District of Himachal Pradesh. The facility Unit I is having production capacity of 6,38,889 units of Sterile Water for Injections per day and Unit II is having a capacity of 40,000 units of dry Powder injection per day and 26,667 units of dry syrup per day in a single shift.

The Company later on, enhanced the capacity expansion from 130 million unit per annum to 230 million units per annum capacity in 2017-18. Further, the Company commenced their Unit II commercial production in 2023.

Company is planning an IPO of 48,10,000 Fresh Issue Equity Shares.

Onyx Biotec Share Price

Onyx Biotec share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Onyx Biotec Market Cap

Market capitalization of Onyx Biotec indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Onyx Biotec is valued compared to its competitors.

Onyx Biotec PE Ratio

Onyx Biotec PE ratio helps investors understand what is the market value of each stock compared to Onyx Biotec 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Onyx Biotec PEG Ratio

The PEG ratio of Onyx Biotec evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Onyx Biotec ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Onyx Biotec generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Onyx Biotec ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Onyx Biotec in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Onyx Biotec Total Debt

Total debt of Onyx Biotec shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Onyx Biotec Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Onyx Biotec compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Onyx Biotec CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Onyx Biotec over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Onyx Biotec Technical Analysis

Technical analysis of Onyx Biotec helps investors get an insight into when they can enter or exit the stock. Key components of Onyx Biotec Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Onyx Biotec shares often struggle to rise above due to selling pressure.

Onyx Biotec Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Onyx Biotec ’s financial health and profitability.

Onyx Biotec Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Onyx Biotec Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Onyx Biotec Financials

The financials of Onyx Biotec provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Onyx Biotec Profit and Loss Statements

The profit and loss statement of Onyx Biotec highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Onyx Biotec .

Onyx Biotec Balance Sheet

The balance sheet presents a snapshot of Onyx Biotec ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Onyx Biotec Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App